Nelarabine

DB01280ApprovedInvestigationalSmall moleculeNucleoside Metabolic Inhibitor

Nelarabine is a purine nucleoside analog and antineoplastic agent used for the treatment of with acute T-cell lymphoblastic leukemia and T-cell lymphoblastic lymphoma with inadequate clinical response to prior chemotherapeutic treatments. Nelarabine is an antineoplastic agent that is typically used to treat acute T-cell lymphoblastic leukemia, particularly T-cell acute lymphoblastic leukemia (T-ALL) and T-cell lymphoblastic lymphoma (T-LBL), in both adult and pediatric patients whose disease has...

Chemical structure of Nelarabine
Mechanism
Curator reviewed · 9 references
Primary indication
ARRANON is indicated for the treatment of T-cell acute lymphoblastic leukemia (T-ALL) and T-cell lymphoblastic lymphoma (T-LBL) in adult and pediatric patients age 1 year and older whose disease has not responded to or has...Curator reviewed · 2 structured indications
Formula / weight
C11H15N5O5 · 297.2673 g/mol (avg)
First approval
Canada, 2022 · United States, 2006 · European Union, 2016
Also known as
Nelzarabine
Code names
506U · 506U78 · GW-506U78
Brand names
  • Arranon
  • Atriance

Resolves to

Structure
InChIKeyIXOXBSCIXZEQEQ-UHTZMRCNSA-NSMILESCOC1=NC(N)=NC2=C1N=CN2[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O

What you can answer from here — as of September 23, 2026

5Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
1,233Drug interactionsStructured to mechanism, not free text
Sign in
31Clinical trialsPhase, status and sponsor resolved per trial
Sign in
2Structured indicationsCondition, population, route and combination as fields, not prose
Sign in
2ContraindicationsEach with its own population and attribute set
Sign in
27Marketed productsAcross 5 countries and 18 labellers
Sign in
1ATC codeIncluding every combination product, plus 13 drug categories
Sign in
52+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Nelarabine, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.

Create Account